Selectively targeting PI3K isoforms to treat glioblastoma

被引：0
|
作者：
Pridham, Kevin J. [1 ]
Le, Lamvy [2 ]
Guo, Sujuan [1 ]
Varghese, Robin T. [3 ]
Liang, Yanping [1 ]
Rodgers, Cara M. [4 ]
Simonds, Gary R. [4 ]
Kelly, Deborah F. [2 ]
Sheng, Zhi [2 ]
机构：
[1] Virginia Tech, Carilion Res Inst, Roanoke, VA USA
[2] Virginia Tech, Carilion Sch Med & Res Inst, Roanoke, VA USA
[3] Edward Via Coll Osteopath Med, Blacksburg, VA USA
[4] Carilion Clin, Roanoke, VA USA
来源：
MOLECULAR CANCER RESEARCH | 2020年 / 18卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A18
引用
收藏
页码：36 / 37
页数：2
相关论文
共 50 条
  • [1] Targeting Class IA PI3K Isoforms Selectively Impairs Cell Growth, Survival, and Migration in Glioblastoma
    Hoeland, Katrin
    Boller, Danielle
    Hagel, Christian
    Dolski, Silvia
    Treszl, Andras
    Pardo, Olivier E.
    Cwiek, Paulina
    Salm, Fabiana
    Leni, Zaira
    Shepherd, Peter R.
    Styp-Rekowska, Beata
    Djonov, Valentin
    von Bueren, Andre O.
    Frei, Karl
    Arcaro, Alexandre
    PLOS ONE, 2014, 9 (04):
  • [2] Targeting PI3K isoforms in multiple myeloma
    Sun, K.
    Karolova, J.
    Jin, L.
    Lenz, G.
    Khandanpour, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 202 - 202
  • [3] Targeting PI3K
    Cantley, L.
    Lewis, C. Cantley
    CANCER RESEARCH, 2012, 72
  • [4] Attenuating PI3K isoforms in pancreatic cancer: Focus on immune PI3Kγ
    Basset, C.
    Guillermet-Guibert, J.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017, 41 (04) : 351 - 353
  • [5] Targeting PI3K in neuroblastoma
    Spitzenberg, Volker
    Koenig, Christian
    Ulm, Susanne
    Marone, Romina
    Roepke, Luise
    Mueller, Joerg P.
    Gruen, Michael
    Bauer, Reinhard
    Rubio, Ignacio
    Wymann, Matthias Paul
    Voigt, Astrid
    Wetzker, Reinhard
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (12) : 1881 - 1890
  • [6] Targeting PI3K in neuroblastoma
    Volker Spitzenberg
    Christian König
    Susanne Ulm
    Romina Marone
    Luise Röpke
    Jörg P. Müller
    Michael Grün
    Reinhard Bauer
    Ignacio Rubio
    Matthias Paul Wymann
    Astrid Voigt
    Reinhard Wetzker
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1881 - 1890
  • [7] TARGETING EGFR/PI3K/AKT REGULATED SREBP-1/LDLR MEDIATED CHOLESTEROL METABOLISM TO TREAT GLIOBLASTOMA
    Guo, Deliang
    Reinitz, Felicia
    Youssef, Mary
    Hong, Cynthia
    Nathanson, David
    Akhavan, David
    Kuga, Daisuke
    Amzajerdi, Ali Nael
    Soto, Horacio
    Zhu, Shaojun
    Babic, Ivan
    Iwanami, Akio
    Tanaka, Kazuhiro
    Gini, Beatrice
    DeJesus, Jason
    Lisiero, Dominique D.
    Huang, Tiffany
    Prins, Robert
    Wen, Patrick
    Robbins, H. Ian
    Prados, Michael
    DeAngelis, Lisa
    Mellinghoff, Ingo
    Mehta, Minesh
    James, C. David
    Chakravarti, Arnab
    Cloughesy, Timothy
    Tontonoz, Peter
    Mischel, Paul
    NEURO-ONCOLOGY, 2011, 13 : 70 - 71
  • [8] Targeting PI3K isoforms to improve the effectiveness of T cell mediated immunotherapy
    Bohat, Ritu
    Liang, Xiaofang
    Xu, Chunyu
    Tang, Yitao
    Hou, Jiakai
    Egan, Nicholas A.
    Shi, Leilei
    Guerrero, Ashley
    Jaffery, Roshni
    Burton, Elizabeth M.
    Liang, Han
    Tawbi, Hussein
    Davies, Michael A.
    Peng, Weiyi
    CANCER RESEARCH, 2023, 83 (07)
  • [9] Targeting PI3K isoforms in cancer: From mouse genetics to human therapy
    Zhao, Jean J.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07)
  • [10] The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma
    Saito, Norihiko
    Hirai, Nozomi
    Aoki, Kazuya
    Suzuki, Ryo
    Fujita, Satoshi
    Nakayama, Haruo
    Hayashi, Morito
    Ito, Keisuke
    Sakurai, Takatoshi
    Iwabuchi, Satoshi
    CANCERS, 2019, 11 (01):
12345